Simpósios patrocinados no Congresso SOLACI-SOCIME 2025
ATIVIDADES COM PARTICIPAÇÃO DA INDÚSTRIA
A seguir, apresentamos atividades científicas inovadoras com o apoio da indústria, abordando os temas mais relevantes da cardiologia intervencionista na atualidade.
Inscrições para o SOLACI-SOCIME 2025
*Todos os simpósios patrocinados ocorrerão das 13h30 às 14h30.
*Informações preliminares.
QUARTA-FEIRA, 6 DE AGOSTO
01.30 pm - Main Arena
| LUNCH SYMPOSIUM. MERIL. TAVR | |||
 | 10' | Lifetime management of patients with TAVI | |
| 10' | Landmark Updates and Deepdive | |
| 10' | My Experience with Myval Octacor (Complicated Case Presentation) | |
| 10' | Compare TAVI Update | |
| 10' | Discussion | |
01.30 pm - Sala A1
| How OCT and the Ultreon 2.0 imaging software can help you perform PCI in Calcified Lesions | ||
|---|---|---|
| 10' | Unlocking the Power of Ultreon 2.0. |
| 10' | Seeing the Unseen: OCT in Calcium Detection and Treatment Planning |
| 10' | Clinical Case Illustration |
| 10' | Clinical Case Illustration |
| 10' | Discussion |
01.30 pm - Sala A3
| Optimal Strategies for Complex PCI with APT Medical | ||
|---|---|---|
| 15' | Two scenarios, one goal: Effective revascularization techniques in complex anatomies |
| 15' | Anyreach, anywhere: From Workhorse to complex PCI |
| 15' | Dual lumen microcatheter in complex scenarios: CTO and reverse wiring |
| 15' | Discussion |
QUINTA-FEIRA, 7 DE AGOSTO
01.30 pm - Sala A1
| Transforming PE Care: Treating with a Lytic Free Approach and Large-Bore Mechanical Thrombectomy | ||
|---|---|---|
| 5' | Welcome and Opening Remarks |
| 15' | Why Intervene: The clinical case for mechanical thrombectomy in PE |
| 15' | From Diagnosis to Treatment: A practical approach to treating patients with large-bore device, FlowTriever |
| 15' | Driving better outcomes through program building and multidisciplinary collaboration |
| 10' | Q&A Panel Session |
01.30 pm - Sala A2
| P-Valve in Focus: A Decade of Evolving Solutions for RVOT Dysfunction | ||
|---|---|---|
| 12' | Advanced Imaging in PPVI: Optimizing Outcomes |
| 12' | A-to-Z with P-Valve-The TPVI Procedure |
| 12' | Built to Last: P-Valve in Complex TPVI |
| 12' | VenusP – A Decade of Data and the Road Ahead |
| 12' | Discussion |
01.30 pm - Sala A3
| Transforming PCI: Mastering the implementation of drug-eluting balloons (DEB) | ||
|---|---|---|
| Welcome & Framing | |
| The Evidence Base. Rationale and key clinical trials supporting DEBs | |
| Clinical Applications. Use in standard vs. complex lesions | |
| Mechanistic Rationale. Drug delivery, vessel healing, and drug choice | |
| Comparative Perspectives. DEBs vs. stents: when to choose what | |
| Panel Q&A | |
| Closing Remarks | |
01.30 pm - Sala B1
| Tricuspid Regurgitation: The Forgotten Valve No More! | ||
|---|---|---|
| 3' | Welcome |
| 20' | The Rise of a Disruptive Technology |
| 10' | Latest Evidence and Key Clinical Cases |
| Expert Panel: Case Discussion and Clinical Insights | |
| 10' | Case 1 |
| 10' | Case 2 |
| 3' | Audience Q&A |
| 4' | Session Closure |
01.30 pm - Sala B2
| The Interventional Cardiology. State of mind based on clinical cases discussion | ||
|---|---|---|
| 25' | Feasibility of coronary access post TAVI is based on bioprosthetic design: Myth or Fact? |
| 25' | Understanding the technique of PCI with DCB: Should we change our approach and expectations? |
| 10' | Discussion |
SEXTA-FEIRA, 8 DE AGOSTO
02.00 pm - MAIN ARENA
| VENUS Medtech Aortic Portfolio: Innovation, Clinical Data & Global Adoption | ||
|---|---|---|
| 3' | Welcome and Opening Remarks |
| 8' | Venus Aortic Portfolio & A-Pro Clinical Insights |
| 8' | PowerX: A New Era in TAVI Technology and LATAM Clinical Experience |
| 8' | Vitae Valve: Clinical Advantages & Operator Perspective |
| 25' | Live Case from Chile Instituto Nacional : PowerX - a Noval Fully Retrievable Self-Expanding Dry-Tissue Valve |
| 5' | Panel Discussion and Q&A |
| 3' | Closing Remarks |